We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immunology

Image: The finger-based test takes a minute to noninvasively capture enough information to evaluate white cell levels (Photo courtesy of Leuko Labs)

Portable Device Analyzes White Blood Cell Activity to Monitor Cancer Patients’ Health

An at-home white blood cell monitor can detect low white blood cell counts in cancer patients without drawing blood, offering doctors the ability to remotely monitor their health. More...
21 Jun 2024
Image: The new test’s measurement is a thousand times more sensitive than current standard test (Photo courtesy of 123RF)

New Test Detects Return of Blood Cancer a Year Earlier

A new blood test can detect the return of multiple myeloma a full year earlier than the current standard blood test by measuring antibodies produced by plasma cells, which are crucial to immune defense. More...
19 Jun 2024
Image: PROMAD is a molecular atlas consisting of more than 12,000 patient samples from around the globe (Photo courtesy of WIMR)

Universal Blood Test Could Predict Organ Transplant Outcomes with Unprecedented Accuracy

Researchers have identified common molecular biomarkers for transplant rejection across major transplanted organs, paving the way for a blood test that could enable physicians to predict and prevent organ rejection. More...
19 Jun 2024
Image: The AI tool predicts whether someone’s cancer will respond to immune checkpoint inhibitors (Photo courtesy of National Cancer Institute)

AI Tool Predicts Cancer Patients’ Response to Immunotherapy

Researchers have created an AI tool that uses standard clinical data, such as results from a basic blood test, to predict if a patient’s cancer will respond to immune checkpoint inhibitors. More...
05 Jun 2024
Image: Initially aimed at children with high-risk cancers, ZERO now includes all young cancer patients in Australia (Photo courtesy of Zero Childhood Cancer)

Molecular Profiling Improves Diagnosis for Children with High Risk Cancers

Researchers have demonstrated that through precision medicine, not only can diagnoses be more accurate, but implementing precision-guided, targeted treatments earlier can also enhance the two-year progression-free survival rates for young cancer patients. More...
03 Jun 2024
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

A novel blood test that measures the immune response to the Epstein-Barr Virus (EBV) provides new avenues for basic research into EBV's role in multiple sclerosis and potential applications in clinical trials aimed at targeting the virus. More...
24 May 2024
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Scientists have employed artificial intelligence to create a predictive model that can identify the most potent cancer-killing immune cells for use in cancer immunotherapies. More...
16 May 2024
Gold Member
Hematology Analyzer
Medonic M32B
Collection and Transport System
PurSafe Plus®
Hemodynamic System Monitor
OptoMonitor
New
Silver Member
PCR Plates
Diamond Shell PCR Plates


The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.